Get the Stockscreener App
14.36
2.72%
0.38
After Hours:
14.08
-0.28
-1.95%
Gh Research Plc stock is traded at $14.36, with a volume of 408.39K.
It is up +2.72% in the last 24 hours and up +17.80% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$13.98
Open:
$13.88
24h Volume:
408.39K
Relative Volume:
1.98
Market Cap:
$747.12M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-18.18
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
-0.90%
1M Performance:
+17.80%
6M Performance:
+35.47%
1Y Performance:
+15.81%
1-Day Range:
$13.78
$14.75
1-Week Range:
$13.78
$15.28
52-Week Range:
$6.00
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.36 | 867.17M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Ranking GH Research PLC among high performing stocks via toolsFree Optimized Watchlist With Daily Adjustments - Newser
Volatility clustering patterns for GH Research PLCGrowth Summary Based on Market Positioning - Newser
What candlestick patterns are forming on GH Research PLCBuy Signal Forecast With Short-Term Data - Newser
Will earnings trigger a reversal in GH Research PLCBuy and Hold Position Summary Review - Newser
Will GH Research PLC see short term momentumQuarterly Investment Outlook and Key Summary - Newser
GH Research PLC stock trend forecastFree AI-Powered Trade Planning with Indicators - Newser
Why GH Research PLC stock attracts strong analyst attentionSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Will GH Research PLC Bounce From 52 Week LowReliable Investment Entry Signals Confirmed by Charts - metal.it
What does GHRS's flat EPS in 2024 suggest for investors? - AInvest
Published on: 2025-07-29 07:08:26 - Newser
What moving averages say about GH Research PLCEarly Entry Ideas with Momentum Potential - Newser
Competitive Positioning of GH Research PLC: Is It Leading or Lagging Weekly Chart-Based Forecast for Traders - Newser
How does GH Research PLC generate profit in a changing economyMaster stock selection with insider knowledge - jammulinksnews.com
Is it the right time to buy GH Research PLC stockFree Stock Forecasts That Work - jammulinksnews.com
What is GH Research PLC company’s growth strategyDaily Trading Outlook With Proven Results - jammulinksnews.com
What are the latest earnings results for GH Research PLCBuild a portfolio that outperforms the market - jammulinksnews.com
How volatile is GH Research PLC stock compared to the marketExceptional stock performance - jammulinksnews.com
When is GH Research PLC stock expected to show significant growthFree Consultation - jammulinksnews.com
How strong is GH Research PLC company’s balance sheetRapid market gains - jammulinksnews.com
Should I hold or sell GH Research PLC stock in 2025Get daily updates on promising stocks - jammulinksnews.com
What is the dividend policy of GH Research PLC stockBuild wealth with high-performing stocks - jammulinksnews.com
How many analysts rate GH Research PLC as a “Buy”Free Predictions - jammulinksnews.com
What analysts say about GH Research PLC stockUnprecedented profits - PrintWeekIndia
What drives GH Research PLC stock priceConsistent wealth multiplication - PrintWeekIndia
GH Research PLC Stock Analysis and ForecastPowerful growth strategies - PrintWeekIndia
JMP reiterates Market Outperform rating on GH Research stock at $39 target - Investing.com Nigeria
JMP reiterates Market Outperform rating on GH Research stock at $39 target By Investing.com - Investing.com South Africa
GH Research's GH001: A Catalyst-Driven Play in the TRD Market - AInvest
GH Research reports progress on FDA engagement for GH001 IND By Investing.com - Investing.com India
GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results - TipRanks
GH Research reports progress on FDA engagement for GH001 IND - Investing.com
GH Research Announces Global Pivotal Program Plans and Further Development Updates - The Manila Times
Best Dividend Growth Stocks AI Driven Stock ResearchExceptional portfolio growth - Autocar Professional
Is GH Research PLC a good long term investmentPhenomenal returns - jammulinksnews.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):